Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical sevoflurane for chronic painful non-healing ulcers
ACTRN12621001099819Phase 4Completed
- Sponsor
- Anaesthetic Research Department, Waikato Hospital
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of sevoflurane in chronic ulcer and Peptic ulcer disease (PUD), sponsored by Anaesthetic Research Department, Waikato Hospital. Started Nov 2021; status: completed.
02
Drugs
sevoflurane
03
Conditions
chronic ulcerPeptic ulcer disease (PUD)
Beyond the preview
Go deeper on ACTRN12621001099819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12621001099819.